OTCMKTS:FSNUY

Fresenius SE & Co. KGaA Stock Forecast, Price & News

$11.82

+0.25 (+2.16 %)

(As of 01/19/2021 03:59 PM ET)

Add

Compare

Today's Range

$11.71

Now: $11.82▼

$11.86

50-Day Range

$11.16

MA: $11.63▼

$12.30

52-Week Range

$6.61

Now: $11.82▼

$13.76

Volume67,914 shs

Average Volume25,656 shs

Market Capitalization$26.30 billion

P/E Ratio12.99

Dividend Yield1.47%

Beta1.36

Fresenius SE & Co. KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment offers dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment specializes in the therapy and care of chronically and critically ill patients. This segment offers IV drugs, including intravenously administered generic anesthetics, analgesics, anti-infectives, and drugs for the treatment of oncological and other critical diseases; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; infusion and nutrition pumps, as well as consumables; and products that are used in the collection and processing of blood components, as well as in transfusion medicine and cell therapy. As of December 31, 2019, this segment operated 86 hospitals, approximately 125 outpatient clinics, and 8 prevention centers. The Fresenius Vamed segment manages projects and provides services for hospitals and other health care facilities. This segment offers project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. Fresenius SE & Co. KGaA has a strategic partnership with Humacyte Inc. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der HÃ¶he, Germany.

MarketRank^™

Overall MarketRank^™

1.42 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Fresenius SE & Co. KGaA.

2.3 Community Rank

Outperform Votes
Fresenius SE & Co. KGaA has received 172 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Fresenius SE & Co. KGaA has received 206 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Fresenius SE & Co. KGaA has received 54.50% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Fresenius SE & Co. KGaA and other stocks. Vote “Outperform” if you believe FSNUY will outperform the S&P 500 over the long term. Vote “Underperform” if you believe FSNUY will underperform the S&P 500 over the long term. You may vote once every thirty days.

1.7 Dividend Strength

Dividend Yield
Fresenius SE & Co. KGaA has a dividend yield of 1.47%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
Fresenius SE & Co. KGaA does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Fresenius SE & Co. KGaA is 18.09%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Fresenius SE & Co. KGaA will have a dividend payout ratio of 16.35% next year. This indicates that Fresenius SE & Co. KGaA will be able to sustain or increase its dividend.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Fresenius SE & Co. KGaA insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 0.06% of the stock of Fresenius SE & Co. KGaA is held by institutions.

3.1 Earnings and Valuation

Earnings Growth
Earnings for Fresenius SE & Co. KGaA are expected to grow by 8.33% in the coming year, from $0.96 to $1.04 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Fresenius SE & Co. KGaA is 12.99, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 22.93.
Price to Earnings Ratio vs. Sector
The P/E ratio of Fresenius SE & Co. KGaA is 12.99, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 29.04.
Price to Book Value per Share Ratio
Fresenius SE & Co. KGaA has a P/B Ratio of 0.88. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Surgical & medical instruments

Sub-IndustryN/A

SectorMedical

Current SymbolOTCMKTS:FSNUY

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.fresenius.com

Phone49-6172-6080

Employees294,134

Debt

Debt-to-Equity Ratio0.68

Current Ratio1.21

Quick Ratio0.92

Price-To-Earnings

Trailing P/E Ratio12.99

Forward P/E Ratio12.31

P/E GrowthN/A

Sales & Book Value

Annual Sales$39.66 billion

Price / Sales0.66

Cash Flow$2.19 per share

Price / Cash Flow5.40

Book Value$13.38 per share

Price / Book0.88

Profitability

EPS (Most Recent Fiscal Year)$0.94

Net Income$2.11 billion

Net Margins4.99%

Return on Equity6.74%

Return on Assets2.63%

Miscellaneous

Outstanding Shares2,225,290,000

Market Cap$26.30 billion

Next Earnings Date2/17/2021 (Estimated)

OptionableNot Optionable

$11.82

+0.25 (+2.16 %)

(As of 01/19/2021 03:59 PM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive FSNUY News and Ratings via Email

Sign-up to receive the latest news and ratings for FSNUY and its competitors with MarketBeat's FREE daily newsletter.

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Frequently Asked Questions

How has Fresenius SE & Co. KGaA's stock price been impacted by COVID-19 (Coronavirus)?

Fresenius SE & Co. KGaA's stock was trading at $10.13 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, FSNUY stock has increased by 14.2% and is now trading at $11.57.
View which stocks have been most impacted by COVID-19.

Is Fresenius SE & Co. KGaA a buy right now?

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Fresenius SE & Co. KGaA in the last year. There are currently 1 sell rating, 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Fresenius SE & Co. KGaA stock.
View analyst ratings for Fresenius SE & Co. KGaA or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Fresenius SE & Co. KGaA?

Wall Street analysts have given Fresenius SE & Co. KGaA a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Fresenius SE & Co. KGaA wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Fresenius SE & Co. KGaA's next earnings date?

Fresenius SE & Co. KGaA is scheduled to release its next quarterly earnings announcement on Wednesday, February 17th 2021.
View our earnings forecast for Fresenius SE & Co. KGaA.

How were Fresenius SE & Co. KGaA's earnings last quarter?

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) issued its quarterly earnings data on Thursday, October, 29th. The company reported $0.22 earnings per share for the quarter. The firm had revenue of $10.42 billion for the quarter. Fresenius SE & Co. KGaA had a net margin of 4.99% and a return on equity of 6.74%.
View Fresenius SE & Co. KGaA's earnings history.

How often does Fresenius SE & Co. KGaA pay dividends? What is the dividend yield for Fresenius SE & Co. KGaA?

Fresenius SE & Co. KGaA declared an annual dividend on Friday, July 10th. Shareholders of record on Tuesday, September 1st will be given a dividend of $0.16 per share on Thursday, September 10th. This represents a dividend yield of 1.28%. The ex-dividend date is Monday, August 31st. This is a boost from Fresenius SE & Co. KGaA's previous annual dividend of $0.15.
View Fresenius SE & Co. KGaA's dividend history.

Is Fresenius SE & Co. KGaA a good dividend stock?

Fresenius SE & Co. KGaA pays an annual dividend of $0.17 per share and currently has a dividend yield of 1.47%. The dividend payout ratio of Fresenius SE & Co. KGaA is 18.09%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Fresenius SE & Co. KGaA will have a dividend payout ratio of 16.35% next year. This indicates that Fresenius SE & Co. KGaA will be able to sustain or increase its dividend.
View Fresenius SE & Co. KGaA's dividend history.

Are investors shorting Fresenius SE & Co. KGaA?

Fresenius SE & Co. KGaA saw a drop in short interest in December. As of December 31st, there was short interest totaling 700 shares, a drop of 92.7% from the December 15th total of 9,600 shares. Based on an average daily volume of 82,000 shares, the days-to-cover ratio is presently 0.0 days.
View Fresenius SE & Co. KGaA's Short Interest.

Who are some of Fresenius SE & Co. KGaA's key competitors?

Some companies that are related to Fresenius SE & Co. KGaA include 3M (MMM), Stryker (SYK), Becton, Dickinson and (BDX), Boston Scientific (BSX), Baxter International (BAX), DexCom (DXCM), ResMed (RMD), Teleflex (TFX), Insulet (PODD), NovoCure (NVCR), Abiomed (ABMD), Penumbra (PEN), iRhythm Technologies (IRTC), Hill-Rom (HRC) and Globus Medical (GMED).
View all of FSNUY's competitors.

Who are Fresenius SE & Co. KGaA's key executives?

Fresenius SE & Co. KGaA's management team includes the following people:

Mr. Stephan Sturm, CEO, Pres & Chairman of Management Board - Fresenius Management SE (Age 57)
Ms. Rachel Clare Empey, CFO & Member of Management Board - Fresenius Management SE (Age 44)
Dr. Francesco De Meo, Member of Management Board - Fresenius Management SE (Age 57)
Dr. Ernst Wastler, Member of Management Board - Fresenius Management SE (Age 62)
Mr. Mats Christer Henriksson, Member of Management Board - Fresenius Management SE (Age 53)
Mr. Rice Powell, Member of Management Board - Fresenius Management SE (Age 65)
Dr. Sebastian Biedenkopf, Chief Legal & Compliance Officer, Insurance, HR, Labor Relations Director and Member of Mgmt. Board (Age 56)
Mr. Markus Georgi, Sr. VP of Investor Relations

What is Fresenius SE & Co. KGaA's stock symbol?

Fresenius SE & Co. KGaA trades on the OTCMKTS under the ticker symbol "FSNUY."

How do I buy shares of Fresenius SE & Co. KGaA?

Shares of FSNUY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Fresenius SE & Co. KGaA's stock price today?

One share of FSNUY stock can currently be purchased for approximately $11.57.

How big of a company is Fresenius SE & Co. KGaA?

Fresenius SE & Co. KGaA has a market capitalization of $25.75 billion and generates $39.66 billion in revenue each year. The company earns $2.11 billion in net income (profit) each year or $0.94 on an earnings per share basis. Fresenius SE & Co. KGaA employs 294,134 workers across the globe.

What is Fresenius SE & Co. KGaA's official website?

The official website for Fresenius SE & Co. KGaA is www.fresenius.com.

How can I contact Fresenius SE & Co. KGaA?

Fresenius SE & Co. KGaA's mailing address is Else-Kroner-Strasse 1, Bad Homburg 2M, 61352. The company can be reached via phone at 49-6172-6080 or via email at [email protected]

This page was last updated on 1/19/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here